Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Trial details
- Registry ID
- NCT06325566
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainNCT06325566 | MESO | Phase 3 | Active not recruiting | 2027-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |